Specify a stock or a cryptocurrency in the search bar to get a summary
Regencell Bioscience Holdings Ltd
RGCRegencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong. Address: Chinachem Leighton Plaza, Causeway Bay, Hong Kong
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures RGC
Dividend Analytics RGC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RGC
Stock Valuation RGC
Financials RGC
Results | 2019 | Dynamics |